NasdaqCM - Nasdaq Real Time Price USD

Pulse Biosciences, Inc. (PLSE)

17.10
+0.78
+(4.78%)
At close: June 6 at 4:00:00 PM EDT
17.10
0.00
(0.00%)
After hours: June 6 at 4:01:34 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
700
1,418
Cost of Revenue
--
--
0
11,944
1,968
Gross Profit
--
--
0
-11,244
-550
Operating Expense
63,686
56,257
43,574
46,813
62,464
Operating Income
-63,686
-56,257
-43,574
-58,057
-63,014
Net Non Operating Interest Income Expense
3,443
2,672
1,364
-448
-646
Pretax Income
-60,243
-53,585
-42,210
-58,505
-63,660
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-60,243
-53,585
-42,210
-58,505
-63,660
Diluted NI Available to Com Stockholders
-60,243
-53,585
-42,210
-58,505
-63,660
Basic EPS
-0.99
-0.92
-0.85
-1.69
-2.24
Diluted EPS
-0.99
-0.92
-0.85
-1.69
-2.24
Basic Average Shares
60,898.50
58,398
49,737
34,510.34
28,438.10
Diluted Average Shares
60,898.50
58,398
49,737
34,510.34
28,438.10
Total Operating Income as Reported
-63,686
-56,257
-43,574
-58,057
-63,014
Total Expenses
63,686
56,257
43,574
58,757
64,432
Net Income from Continuing & Discontinued Operation
-60,243
-53,585
-42,210
-58,505
-63,660
Normalized Income
-60,243
-53,585
-42,210
-58,505
-63,660
Net Interest Income
3,443
2,672
1,364
-448
-646
EBIT
-63,686
-56,257
-43,574
-58,057
-63,014
EBITDA
-62,524
-55,079
-42,367
-56,702
-61,868
Reconciled Cost of Revenue
--
--
0
11,944
1,968
Reconciled Depreciation
1,162
1,178
1,207
1,355
1,146
Net Income from Continuing Operation Net Minority Interest
-60,243
-53,585
-42,210
-58,505
-63,660
Normalized EBITDA
-62,524
-55,079
-42,367
-56,702
-61,868
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/18/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HBI.MU Harvard Bioscience Inc
0.3460
-3.89%
 
STXS Stereotaxis, Inc.
2.2500
+0.45%
 
SRT.DE Sartorius Aktiengesellschaft
167.00
+0.97%
 
ATRC AtriCure, Inc.
34.94
+0.20%
 
STAA STAAR Surgical Company
17.87
+2.70%
 
KMTS Kestra Medical Technologies, Ltd.
20.70
+3.71%
 
EMBC Embecta Corp.
9.79
-1.90%
 
NVST Envista Holdings Corporation
18.73
+0.27%
 
WST West Pharmaceutical Services, Inc.
224.69
+2.80%
 
RGEN Repligen Corporation
128.30
+1.26%